Companies similar to CARTHERICS
Sign up to Download

1-30 of 6,433,312 results

  • edity-tx.com
  • 1
  • 1
Edity is developing an exciting new platform that harnesses the immune system to deliver therapeutic proteins direct to the cytoplasm of target cells to reprogram cells and tissue back to health... Edity's technology integrates therapeutic proteins..
Relevance: 29.729733
  • kancera.com
  • 5
  • 1
  • 9
Kancera is developing a new class of small molecule drug candidates that control disease promoting immune cells and cancer cells with precision...
Relevance: 28.99333
  • renovarobio.com
  • 6
Renovaro Biosciences is developing a novel platform of therapeutic cancer vaccines using allogenic dendritic cells that are genetically engineered by design to bypass tumor immune response evasion and enhance tumor eradication. Dendritic cells are..
Relevance: 28.281754
  • jabious.com
  • 1
  • 2
JA Bio is a startup bio-tech company located at Cambridge in Massachusetts. We are focusing on anti-cancer cell immune therapeutics discovery and development. Our research includes,... Based on NBRL (nbrm.org) developed immune cell therapy, JA Bio..
Relevance: 27.906599
  • neuronity.net
  • 1
  • 4
Neuronity is a biotech startup company developing First-in-Class immune therapy for age-related neurodegenerative diseases... Our team of scientists develop innovative therapies to boost healthy immune cells in aged nervous system and prevent the..
Relevance: 27.708887
  • www.scancell.co.uk
  • 2
  • 14
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer..
Relevance: 27.496853
  • avmbiotech.com
  • 1
  • 8
AVM Biotechnology is a clinical-stage company, founded by Theresa Deisher, Ph.D. The company is developing AVM0703, a proprietary and innovative therapeutic option for cancer and autoimmune diseases. AVM's passion is to deliver drugs that are..
Relevance: 27.315466
  • cartherics.com
  • 1
  • 2
  • 18
Cartherics is developing its novel "off-the-shelf" (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human..
Relevance: 27.231676
  • www.haemalogix.com
  • 1
  • 13
HaemaLogiX is researching immune based treatments (Monoclonal Antibodies, CAR T cell therapies and Bispecific antibodies) that target unique antigens on malignant cells to treat patients suffering from blood cancers (Multiple Myeloma) and other life-..
Relevance: 27.176666
  • www.immunotreatment.org
  • 2
Cancer cells are formed in our body every day. Shocking? Yes it is true. It is because when normal cells divide, due to various factors abnormal cells are also formed along with the normal cells. These cells are sensed by the immune surveillance..
Relevance: 27.152199
  • tumor-immunology-lab.nl
  • 1
  • 1
  • 2
Research within the Tumor Immunology department aims at a better understanding of our immune system using molecular, cell biological and immunological techniques. Our research is centered around dendritic cells, B cells and regulatory T cells which..
Relevance: 26.7113
  • sabatinolab.ucsf.edu
  • 1
  • 3
To identify the targets and functions of T cells in multiple sclerosis (MS) with the goal of developing novel immune biomarkers and therapeutics...
Relevance: 26.54626
  • www.allakos.com
  • 7
  • 1
  • 15
Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases... We are a clinical stage biotechnology company developing therapeutic antibodies to treat..
Relevance: 26.470459
  • allarta.com
  • 1
  • 12
Allarta is a pre-clinical life science company with platform technology to deliver curative cell and stem cell therapies... Allarta Life Science is a pre-clinical life science company based in Hamilton, Ontario, Canada, developing next generation..
Relevance: 26.392311
  • www.eitrbio.com
  • 1
  • 3
We are developing the world's smallest single domain bispecific to enhance penetration of solid tumors and create a tighter immune synapse between tumor cells and effector cells... Our Orthogonal Dual-Interacting Nanotherapeutic (ODIN) platform is..
Relevance: 25.829285
  • vectiopep.ee
  • 1
  • 3
Vectiopep is focusing on selective activation of the patient's innate immune system to fight cancer. We achieve this by transporting the molecular message (mRNA) very selectively into the immune cells in the patients' body. Because Vectiopep achieves..
Relevance: 25.82087
  • eng.immunique.co.kr
  • 1
  • 1
  • 3
IMMUNIQUE is a R&D company developing solutions for intractable diseases such as autoimmune disorders and solid tumors utilizing immune cells (regulatory-T and NK cells) derived from the cord blood... IMMUNIQUE is developing cellular immunotherapy..
Relevance: 25.708612
  • immunobrain.com
  • 2
  • 18
ImmunoBrain Checkpoint is a clinical-stage biopharmaceutical company committed to developing innovative immunotherapies for neurological disorders... At ImmunoBrain Checkpoint, we are pioneering a paradigm shift, building on the groundbreaking..
Relevance: 25.686024
  • kirabiotech.com
  • 1
Kira Biotech is an emerging Australian biotechnology company developing novel immunomodulatory compounds for the treatment of immune system disorders. Its lead candidate, KB312, is a first-in-class, selective, immune-cell depleting monoclonal..
Relevance: 25.61336
  • www.amorlab.org
  • 2
  • 2
  • 2
Our lab studies cellular senescence. Senescence is a stress response program that is triggered in damaged cells and leads to their elimination by the immune system. If uncleared, the accumulation of senescent cells generates a chronic pro-..
Relevance: 25.469477
  • www.dc4u-technologies.nl
  • 2
  • 1
  • 2
DC4U is a life science company developing technologies that enable steering the human immune response. Our GlycoDC TM technology can either potentiate or suppress the immune system via specific targeting of dendritic cells by glycan modified antigen..
Relevance: 25.467354
  • birnbaumlab.com
  • 13
  • 3
  • 14
The Birnbaum Lab is part of the Koch Institute for Integrative Cancer Research at MIT. Our lab is focused on understanding and manipulating immune recognition, using protein engineering in cells to create novel immune treatments, and developing..
Relevance: 25.453445
  • www.kurometherapeutics.com
  • 1
  • 1
  • 14
Kurome® Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms...
Relevance: 25.446686
  • www.marsonlab.org
  • 28
  • 59
The Marson lab is a team of highly collaborative students, research technicians, and postdoctoral scientists with expertise across the fields of genomics, immunology, infectious diseases and genome engineering... The goal of our lab is to understand..
Relevance: 25.398067
  • www.biotecnol.com
  • 8
Biotecnol is a private biopharmaceutical company working in the field of immuno-oncology. Biotecnol develops highly-specific antibody-based immunotherapies which activates and directs the defences of a patient's own immune system, such as their own..
Relevance: 25.384354
  • singularimmune.com
  • 3
Singular Immune's platform allows for the creation of iCAR and iHAR with recombinant fusion protein. These technologies allow for the modification of immune cells and stem cells within the patient's body. The iCAR technology focuses on treating..
Relevance: 25.374239
  • www.immvirx.com
  • 2
  • 12
ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect... ImmVirX was founded in July 2019 by the team from Viralytics, a clinical-..
Relevance: 25.263
  • syncromune.com
  • 2
  • 16
Syncromune® is developing SYNC-T™, a disruptive platform technology designed to optimize IN SITU NEOANTIGEN T CELL EDUCATION AND IMMUNOSTIMULATION... Syncromune™ is developing SYNC-T™, a disruptive platform immunotherapy designed to optimize T cells..
Relevance: 25.160501
  • cellvx.com
  • 1
CellVax Therapeutics is a privately-held clinical-stage company active in research, development, and innovation on human immunodiagnostic and autologous anticancer vaccines. CellVax Therapeutics has developed a proprietary autologous tumor cell-based..
Relevance: 24.98586
  • spitzerlab.org
  • 2
  • 33
In the Spitzer Lab, we are passionate about developing better immune-based treatments for cancer and other diseases informed by fundamental scientific discovery... The Spitzer Lab is a group of scientists passionate about improving lives through..
Relevance: 24.956861